Surveillance of adverse events after the first trivalent inactivated influenza vaccine produced in mammalian cell culture (Flucelvax®) reported to the Vaccine Adverse Event Reporting System (VAERS), United States, 2013–2015 |
| |
摘 要: |
|
收稿时间: | 2015-08-12 |
本文献已被 ScienceDirect 等数据库收录! |
|